The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort.

By R. Kohansal, Pablo Martínez-Camblor, Alvar Agusti, A. Buist, David M. Mannino, J. Soriano. American Journal of Respiratory and Critical Care Medicine, 2009

641 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine, Sociology and Political Science

View Paper: https://www.semanticscholar.org/paper/4508fc678aed407ff589e5ccba515f9eaef0aa78

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. D. Parums
2. P. Barnes
3. J. Wedzicha
4. Matthew B. Schabath
5. W. Macnee
6. Naresh M. Punjabi
7. P. Calverley

In Pulmonary and Respiratory Medicine

1. D. Parums
2. P. Barnes
3. J. Wedzicha
4. P. Calverley
5. Jorgen Vestbo
6. A. Anzueto
7. Bartolome Celli
8. Matthew B. Schabath

In Sociology and Political Science

1. D. Parums
2. P. Barnes
3. R. Rodríguez-Roisín
4. Jorgen Vestbo
5. S. Hurd
6. J. Wedzicha
7. A. Anzueto
8. P. Calverley

Citations in the corpus

• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017, background): “Cigarette smokers have a higher prevalence of respiratory symptoms and lung function abnormalities, a greater annual rate of decline in FEV1, and a greater COPD mortality rate than non-smokers.(9) Other types of tobacco (e.”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “Cigarette smokers have a higher prevalence of respiratory symptoms and lung function abnormalities, a greater annual rate of decline in FEV1, and a greater COPD mortality rate than nonsmokers (13).”
• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary (2023, positive): “of airway abnormalities, although these methods are less well standardized than those used for emphysema quantification80–82; and, (5) a CT offers information about COPD comorbidities including coronary artery calcifications, pulmonary artery enlargement, bone density and muscle mass, some of which ”
• Characterisation of COPD heterogeneity in the ECLIPSE cohort (2010, background): “In fact, a range of ‘susceptibility levels’ was already suggested by Fletcher and Peto in 1977 [12], and has been more recently confirmed in the Framingham offspring cohort [16], potentially reflecting genetic differences or interactions with other risk factors, such as nutrition or infections.”
• Meta-analyses of genome-wide association studies identify multiple novel loci associated with pulmonary function (2009, background): “3 years of active smoking-related decline based on a mean decline of about 30 mL/yea”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, positive): “У курильщиков сигарет наблюдается повышенная распространенность респираторных симптомов и рас стройств легочной функции, ускоренное ежегодное сни жение ОФВ1 и повышенная смертность от ХОБЛ по срав нению с некурящими [44].”